CVS Health Corporate Other — Revenue decreased by 8.3% to $122.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 47.0%, from $83.00M to $122.00M. Over 3 years (FY 2021 to FY 2025), Corporate Other — Revenue shows a downward trend with a -12.4% CAGR.
An increase may indicate growth in non-core business lines or changes in inter-segment accounting, while a decrease suggests a reduction in these peripheral activities.
This represents the total revenue recognized within the corporate and other segment, which typically includes non-core b...
Varies widely by company structure; often represents a small portion of total revenue compared to core segments.
cvs_segment_corporate_other_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.25M | $180.25M | $180.25M | $142.00M | $188.00M | $83.00M | $105.00M | $75.00M | $115.00M | $111.00M | $142.00M | $83.00M | $133.00M | $96.00M | $133.00M | $122.00M |
| QoQ Change | — | +0.0% | +0.0% | -21.2% | +32.4% | -55.9% | +26.5% | -28.6% | +53.3% | -3.5% | +27.9% | -41.5% | +60.2% | -27.8% | +38.5% | -8.3% |
| YoY Change | — | — | — | -21.2% | — | — | -26.1% | — | -38.8% | +33.7% | +35.2% | +10.7% | +15.7% | -13.5% | -6.3% | +47.0% |